x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Listen to The Lancet Oncology

The Lancet Oncology

The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

science & medicine

All Episodes

28:40

In conversation with... Kadia Petricca and Joyce Kambugu

Listen to The Lancet Oncology ·

2023/05/03

Dr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa”.

en-uk

14:11

In Conversation With... Mark Lythgoe

Listen to The Lancet Oncology ·

2023/03/28

Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit".

en-uk

20:43

In conversation with... Janet Brown

Listen to The Lancet Oncology ·

2023/03/01

Prof Janet Brown (University of Sheffield, Sheffield, UK) discusses the phase 2/3 STAR trial on treatment cessation versus continuation with tyrosine kinase inhibitors in advanced renal cell carcinoma.

en-uk

17:40

In conversation with... Valerie Speirs

Listen to The Lancet Oncology ·

2023/01/30

Prof Valerie Speirs (University of Aberdeen, Aberdeen, Scotland) discusses her Systematic Review on genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers in male breast cancer.

en-uk

23:02

In conversation with... Sameer Bakhshi

Listen to The Lancet Oncology ·

2023/01/04

Prof Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India.

en-uk

08:30

In conversation with... Shankar Siva

Listen to The Lancet Oncology ·

2022/11/28

Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.

en-uk

23:20

In conversation with... Mark Lawler and Richard Sullivan

Listen to The Lancet Oncology ·

2022/11/15

Mark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission.

en-uk

10:33

In conversation with... Samar Alhomoud

Listen to The Lancet Oncology ·

2022/11/01

Samar Alhomoud (King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia) discusses her review on progress and remaining challenges for cancer control in the Gulf Cooperation Council.

en-uk

08:11

In conversation with... Inge Marie Svane

Listen to The Lancet Oncology ·

2022/09/26

Inge Marie Svane (Copenhagen University Hospital, Copenhagen, Denmark) discusses her Review on clinical advances and ongoing trials on mRNA vaccines for cancer treatment.

en-uk

11:39

In conversation with... Eline Giraud and Elise Smolders

Listen to The Lancet Oncology ·

2022/08/31

Eline Giraud and Elise Smolders from the (Radboud University Medical Center, Nijmegen, Netherlands) discuss their Review on QT interval prolongation potential of anticancer and supportive drugs.

en-uk

10:30

In conversation with... Ignace Vergote and Maria Kyrgiou

Listen to The Lancet Oncology ·

2022/07/25

Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers.

en-uk

05:19

In conversation with... David J Pinato

Listen to The Lancet Oncology ·

2022/06/30

David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.

en-uk

30:55

In conversation with... Wilfred Ngwa, Beatrice...

Listen to The Lancet Oncology ·

2022/05/09

Wilfred Ngwa (Harvard Medical School, Boston, MA, USA; Johns Hopkins University, Baltimore, MD, USA; ICT University, Yaounde, Cameroon), Beatrice Wiafe-Addai (Peace and Love Hospital, Kumasi, Ghana), and David Kerr (University of Oxford, Oxford, UK) discuss the Lancet Oncology Commission on cancer in sub-Saharan Africa.

en-uk

13:44

In conversation with... Georgios Lyratzopoulos

Listen to The Lancet Oncology ·

2022/04/28

Georgios Lyratzopoulos (Institute of Epidemiology & Health Care at University College London, London, UK) discusses his population-based study on risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission.

en-uk

12:53

In conversation with... Lisa Iezzoni and Jordan Marchak

Listen to The Lancet Oncology ·

2022/03/29

Lisa Iezzoni (Massachusetts General Hospital, Boston, MA, USA) discusses her Series paper on disabilities and cancer and Jordan Marchak (Children’s Healthcare of Atlanta, Atlanta, GA, USA) discusses her Review on surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors.

en-uk

04:33

In conversation with... Rosie Bradley

Listen to The Lancet Oncology ·

2022/03/01

Rosie Bradley (Oxford Population Health, University of Oxford, Oxford, UK) discusses her Article on aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression.

en-uk

09:56

In conversation with... Yi-Long Wu and Caicun Zhou

Listen to The Lancet Oncology ·

2022/02/01

Prof Yi-Long Wu (Guangdong Lung Cancer Institute, Guangzhou, China) and Prof Caicun Zhou (Shanghai Pulmonary Hospital, Shanghai, China) discuss the GEMSTONE 301 and GEMSTONE 302 trials on sugemalimab versus placebo in non-small-cell lung cancer.

en-uk

07:25

In conversation with... Rebecca Fitzgerald

Listen to The Lancet Oncology ·

2022/02/01

Rebecca Fitzgerald (University of Cambridge, Cambridge, UK) discusses her Article on the use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance.

en-uk

04:05

In conversation with... Elysia Alvarez

Listen to The Lancet Oncology ·

2021/12/31

Elysia Alvarez (UC Davis Comprehensive Cancer Center, Sacramento, USA) discusses her Article on the analysis of the global burden of adolescent and young adult cancer in 2019.

en-uk

06:08

In conversation with... Aju Mathew

Listen to The Lancet Oncology ·

2021/11/30

Aju Mathew (Malankara Orthodox Syrian Church Medical College and Hospital, Kerala, India) discusses his Review on financial toxicity in cancer care in India.

en-uk

209 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事